T1	Participants 36 82	recipients of extended criteria donor kidneys.
T2	Participants 84 117	Patients in the BENEFIT-EXT study
T3	Participants 271 385	Patients who remained on assigned therapy through year 3 were eligible to enter a long-term extension (LTE) study.
T4	Participants 386 413	Three hundred four patients
T5	Participants 472 510	260 continued treatment through year 5
